Search Results - "Affrime, MB"

Refine Results
  1. 1

    QT and QTc Interval With Standard and Supratherapeutic Doses of Darifenacin, a Muscarinic M 3 Selective Receptor Antagonist for the Treatment of Overactive Bladder by Serra, Denise B., Affrime, Melton B., Bedigian, Martin P., Greig, Gerard, Milosavljev, Slavica, Skerjanec, Andrej, Wang, Yibin

    Published in Journal of clinical pharmacology (01-09-2005)
    “…Prolongation of QT interval on an electrocardiogram is a valuable predictor of a drug's ability to cause potentially fatal ventricular tachyarrhythmia…”
    Get full text
    Journal Article
  2. 2

    Loratadine administered concomitantly with erythromycin: pharmacokinetic and electrocardiographic evaluations by Brannan, M D, Reidenberg, P, Radwanski, E, Shneyer, L, Lin, C C, Cayen, M N, Affrime, M B

    Published in Clinical pharmacology and therapeutics (01-09-1995)
    “…To evaluate the effects of coadministration of loratadine and erythromycin on the pharmacokinetics and electrocardiographic repolarization (QTc)…”
    Get more information
    Journal Article
  3. 3

    Comparative Pharmacokinetics of Oral Ceftibuten, Cefixime, Cefaclor, and Cefuroxime Axetil in Healthy Volunteers by Nix, David E., Symonds, William T., Hyatt, Judith M., Wilton, John H., Teal, Marilyn A., Reidenberg, Pascale, Affrime, Melton B.

    Published in Pharmacotherapy (01-01-1997)
    “…Study Objective. To compare the pharmacokinetics of ceftibuten, cefixime, cefuroxime axetil, and cefaclor after oral administration. Design. Randomized,…”
    Get full text
    Journal Article
  4. 4

    Pharmacodynamic interaction between the new selective cholesterol absorption inhibitor ezetimibe and simvastatin by Kosoglou, Teddy, Meyer, Ingo, Veltri, Enrico P., Statkevich, Paul, Yang, Bo, Zhu, Yali, Mellars, Lillian, Maxwell, Stephen E., Patrick, James E., Cutler, David L., Batra, Vijay K., Affrime, Melton B.

    Published in British journal of clinical pharmacology (01-09-2002)
    “…Aims  The primary aims of these two single‐centre, randomized, evaluator‐blind, placebo/positive‐controlled, parallel‐group studies were to evaluate the…”
    Get full text
    Journal Article
  5. 5

    Mometasone furoate has minimal effects on the hypothalamic-pituitary-adrenal axis when delivered at high doses by Affrime, M B, Kosoglou, T, Thonoor, C M, Flannery, B E, Herron, J M

    Published in Chest (01-12-2000)
    “…To investigate the potential for mometasone furoate (MF) to exert systemic effects following administration by dry powder inhaler (DPI) or metered-dose inhaler…”
    Get more information
    Journal Article
  6. 6

    Ribavirin dosing in chronic hepatitis C: Application of population pharmacokinetic-pharmacodynamic models by Jen, Juif, Laughlin, Mark, Chung, Carol, Heft, Samuel, Affrime, Melton B., Gupta, Samir K., Glue, Paul, Hajian, Gerald

    Published in Clinical pharmacology and therapeutics (01-10-2002)
    “…Background Combination therapy of ribavirin with interferon alfa‐2b and pegylated interferon alfa‐2b is currently approved for the treatment of chronic…”
    Get full text
    Journal Article
  7. 7

    Attenuation of proinflammatory response by recombinant human IL-10 in human endotoxemia: effect of timing of recombinant human IL-10 administration by Pajkrt, D, Camoglio, L, Tiel-van Buul, MC, de Bruin, K, Cutler, DL, Affrime, MB, Rikken, G, van der Poll, T, ten Cate, JW, van Deventer, SJ

    Published in The Journal of immunology (1950) (15-04-1997)
    “…To determine the effects of IL-10 on cytokine and granulocyte responses during endotoxemia, two groups of eight healthy male volunteers were challenged with…”
    Get full text
    Journal Article
  8. 8

    In vivo effects of interleukin-10 on human cytochrome P450 activity by Gorski, J. Christopher, Hall, Stephen D., Becker, Paula, Affrime, Melton B., Cutler, David L., Haehner‐Daniels, Barbara

    Published in Clinical pharmacology and therapeutics (01-01-2000)
    “…Background Injection of lipopolysaccharide into human volunteers leads to an increase in serum interleukin‐1β, interleukin‐6, and tumor necrosis factor‐α and a…”
    Get full text
    Journal Article
  9. 9

    Bioavailability and Metabolism of Mometasone Furoate following Administration by Metered-Dose and Dry-Powder Inhalers in Healthy Human Volunteers by Affrime, Melton B., Cuss, Francis, Padhi, Desmond, Wirth, Mark, Pai, Sudhakar, Clement, Robert P., Lim, Josephine, Kantesaria, Bhavna, Alton, Kevin, Cayen, Mitchell N.

    Published in Journal of clinical pharmacology (01-11-2000)
    “…These studies were conducted to assess the systemic bioavailability of mometasone furoate (MF) administered by both the dry‐powder inhaler (DPI) and the…”
    Get full text
    Journal Article
  10. 10

    Pharmacodynamics of subcutaneous recombinant human interleukin-10 in healthy volunteers by Huhn, Richard D., Radwanski, Elaine, Gallo, Jose, Affrime, Melton B., Sabo, Ron, Gonyo, Gerilyn, Monge, April, Cutler, David L.

    Published in Clinical pharmacology and therapeutics (01-08-1997)
    “…Interleukin‐10 inhibits T‐lymphocyte activation and proliferation and lipopolysaccharide‐induced monocyte production of proinflammatory cytokines. Fifty‐four…”
    Get full text
    Journal Article
  11. 11

    Safety and tolerability of once-daily mometasone furoate aqueous nasal spray in children by Brannan, Melvin D., Herron, Jerry M., Affrime, Melton B.

    Published in Clinical therapeutics (01-11-1997)
    “…Sensitive and reproducible assessments of hypothalamic-pituitary-adrenal (HPA) axis function were used to assess the systemic exposure and tolerability of…”
    Get full text
    Journal Article Conference Proceeding
  12. 12

    Pharmacokinetics and Immunomodulatory Properties of Intravenously Administered Recombinant Human Interleukin-10 in Healthy Volunteers by Huhn, Richard D., Radwanski, Elaine, O'Connell, Sean M., Sturgill, Marc G., Clarke, Laura, Cody, Ronald P., Affrime, Melton B., Cutler, David L.

    Published in Blood (15-01-1996)
    “…Normal volunteers received single doses of recombinant human interleukin-10 (rhIL-10; n = 6 per group) or placebo (n = 3 per group) by intravenous injection to…”
    Get full text
    Journal Article
  13. 13

    Evaluation of the pharmacokinetics and electrocardiographic pharmacodynamics of loratadine with concomitant administration of ketoconazole or cimetidine by Kosoglou, T., Salfi, M., Lim, J. M., Batra, V. K., Cayen, M. N., Affrime, M. B.

    Published in British journal of clinical pharmacology (01-12-2000)
    “…Aims  To evaluate whether ketoconazole or cimetidine alter the pharmacokinetics of loratadine, or its major metabolite, desloratadine (DCL), or alter the…”
    Get full text
    Journal Article
  14. 14

    Population pharmacokinetics of temozolomide in cancer patients by JEN, J. Frank, CUTLER, David L, PAI, Sudhakar M, BATRA, Vijay K, AFFRIME, Melton B, ZAMBAS, Demetris N, HEFT, Samuel, HAJIAN, Gerald

    Published in Pharmaceutical research (01-10-2000)
    “…To evaluate covariate effects on the pharmacokinetics of temozolomide in cancer patients, and to explore the dose-pharmacokinetics-toxicity relationship of…”
    Get full text
    Journal Article
  15. 15

    The pharmacokinetics, electrocardiographic effects, and tolerability of loratadine syrup in children aged 2 to 5 years by Salmun, Luis M., Herron, Jerry M., Banfield, Christopher, Padhi, Desmond, Lorber, Richard, Affrime, Melton B.

    Published in Clinical therapeutics (01-05-2000)
    “…Abstract We assessed the pharmacokinetics and tolerability of 5 mg loratadine syrup (1 mg/mL) in children aged 2 to 5 years. Two studies were undertaken. A…”
    Get full text
    Journal Article
  16. 16

    Pharmacokinetics and leukocyte responses of recombinant human interleukin-10 by RADWANSKI, E, CHAKRABORTY, A, VAN WART, S, HUHN, R. D, CUTLER, D. L, AFFRIME, M. B, JUSKO, W. J

    Published in Pharmaceutical research (01-12-1998)
    “…To study the pharmacokinetics and ex vivo leukocyte responses of recombinant human IL-10 (rHuIL-10) following single s.c. and i.v. dosing. A randomized two-way…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Regional lung deposition of a technetium 99m-labeled formulation of mometasone furoate administered by hydrofluoroalkane 227 metered-dose inhaler by Pickering, Hannah, Pitcairn, Gary R., Hirst, Peter H., Bacon, Rachel E., Newman, Stephen P., Affrime, Melton B., Marino, Mark

    Published in Clinical therapeutics (01-12-2000)
    “…Background: A new inhaled suspension formulation of mometasone furoate (MF), a potent corticosteroid with minimal systemic availability, has been developed for…”
    Get full text
    Journal Article
  19. 19

    Effects of felbamate on the pharmacokinetics of a low-dose combination oral contraceptive by Saano, V, Glue, P, Banfield, C R, Reidenberg, P, Colucci, R D, Meehan, J W, Haring, P, Radwanski, E, Nomeir, A, Lin, C C

    Published in Clinical pharmacology and therapeutics (01-11-1995)
    “…The effects of felbamate on the pharmacokinetics of a low-dose combination oral contraceptive containing 30 micrograms ethinyl estradiol and 75 micrograms…”
    Get more information
    Journal Article
  20. 20

    Clinical, hematologic, and immunologic effects of interleukin-10 in humans by FUCHS, A. C, GRANOWITZ, E. V, CUTLER, D. L, GRINT, P. C, DINARELLO, C. A, SHAPIRO, L, VANNIER, E, LONNEMANN, G, ANGEL, J. B, KENNEDY, J. S, RABSON, A. R, RADWANSKI, E, AFFRIME, M. B

    Published in Journal of clinical immunology (01-09-1996)
    “…We conducted a double-blind, placebo-controlled study to investigate the safety, pharmacokinetics, and immunological properties of interleukin-10 (IL-10)…”
    Get full text
    Journal Article